Benzodiazepines are among the most frequently prescribed classes of psychotropic me-dications1. They are effective and well tolerated, and they should be prescribed as carefully and judiciously as any other medication. Clinicians and investigators recognize their benefits for ma-ny anxious patients, but some medical “propagandists” 2 have popularized a critical view of the-se medications, which has intruded into the media and even into general medical opinion. For example, because of the possibility of dependence on benzodiazepines, many recent treatment guidelines recommend selective serotonin reuptake inhibitors (SSRIs) as the first-line choice for the treatment for panic disorder (PD). Such recommendations are mainly based on the opinions of some experts and on clinical trials of SSRIs, but evidence from direct drug comparisons of ben-zodiazepines and SSRIs in PD is sparse1. This non-data-based preference for non-benzodiazepine treatments deprives patients with anxiety disorders of potentially valuable treatment with benzo-diazepines.

The Prescription of Benzodiazepines for Panic Disorder / Nardi, Antonio E.; Cosci, Fiammetta; Balon, Richard; Weintraub, Steven J.; Freire, Rafael C.; Krystal, John H.; Roth, Thomas; Silberman, Edward K.; Sonino, Nicoletta; Fava, Giovanni A.; Starcevic, Vladan; Dubovsky, Steven L.; Salzman, Carl; Rickels, Karl; Greenblatt, David J.; Shader, Richard I.; Chouinard, Guy. - In: JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. - ISSN 0271-0749. - ELETTRONICO. - 38:(2018), pp. 1-3. [10.1097/JCP.0000000000000908]

The Prescription of Benzodiazepines for Panic Disorder

Cosci, Fiammetta
Writing – Original Draft Preparation
;
2018

Abstract

Benzodiazepines are among the most frequently prescribed classes of psychotropic me-dications1. They are effective and well tolerated, and they should be prescribed as carefully and judiciously as any other medication. Clinicians and investigators recognize their benefits for ma-ny anxious patients, but some medical “propagandists” 2 have popularized a critical view of the-se medications, which has intruded into the media and even into general medical opinion. For example, because of the possibility of dependence on benzodiazepines, many recent treatment guidelines recommend selective serotonin reuptake inhibitors (SSRIs) as the first-line choice for the treatment for panic disorder (PD). Such recommendations are mainly based on the opinions of some experts and on clinical trials of SSRIs, but evidence from direct drug comparisons of ben-zodiazepines and SSRIs in PD is sparse1. This non-data-based preference for non-benzodiazepine treatments deprives patients with anxiety disorders of potentially valuable treatment with benzo-diazepines.
2018
38
1
3
Nardi, Antonio E.; Cosci, Fiammetta; Balon, Richard; Weintraub, Steven J.; Freire, Rafael C.; Krystal, John H.; Roth, Thomas; Silberman, Edward K.; Sonino, Nicoletta; Fava, Giovanni A.; Starcevic, Vladan; Dubovsky, Steven L.; Salzman, Carl; Rickels, Karl; Greenblatt, David J.; Shader, Richard I.; Chouinard, Guy
File in questo prodotto:
File Dimensione Formato  
Int Task force on BZDs_JCP-D-18-00102-2.pdf

Accesso chiuso

Descrizione: paper
Tipologia: Pdf editoriale (Version of record)
Licenza: Tutti i diritti riservati
Dimensione 92.43 kB
Formato Adobe PDF
92.43 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1129710
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 16
social impact